Entity Details

Primary name PEX7_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO00628
EntryNamePEX7_HUMAN
FullNamePeroxisomal targeting signal 2 receptor
TaxID9606
Evidenceevidence at protein level
Length323
SequenceStatuscomplete
DateCreated1998-07-15
DateModified2021-04-07

Ontological Relatives

GenesPEX7

GO terms

Show/Hide Table
GOName
GO:0001764 neuron migration
GO:0001958 endochondral ossification
GO:0005053 peroxisome matrix targeting signal-2 binding
GO:0005777 peroxisome
GO:0005778 peroxisomal membrane
GO:0005782 peroxisomal matrix
GO:0005829 cytosol
GO:0006635 fatty acid beta-oxidation
GO:0007031 peroxisome organization
GO:0008104 protein localization
GO:0008611 ether lipid biosynthetic process
GO:0016558 protein import into peroxisome matrix
GO:0019899 enzyme binding
GO:0042803 protein homodimerization activity

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Peroxisome

Domains

Show/Hide Table
DomainNameCategoryType
IPR001680 WD40 repeatRepeatRepeat
IPR015943 WD40/YVTN repeat-like-containing domain superfamilyFamilyHomologous superfamily
IPR019775 WD40 repeat, conserved siteSiteConserved site
IPR020472 G-protein beta WD-40 repeatRepeatRepeat
IPR036322 WD40-repeat-containing domain superfamilyFamilyHomologous superfamily
IPR044536 Peroxisomal targeting signal 2 receptorFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
215100 OMIMRhizomelic chondrodysplasia punctata 1 (RCDP1)A peroxisome biogenesis disorder. It is characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe mental retardation with spasticity. The disease is caused by variants affecting the gene represented in this entry.
614879 OMIMPeroxisome biogenesis disorder complementation group 11 (PBD-CG11)A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). The disease is caused by variants affecting the gene represented in this entry.
614879 OMIMPeroxisome biogenesis disorder complementation group 11 (PBD-CG11)A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). The disease is caused by variants affecting the gene represented in this entry.